Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Antibody (PE)

Este producto es parte de UCHL - Ubiquitin C-Terminal Hydrolase L
Product Graph
637€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Antibody (PE)
category
Primary Antibodies
provider
Abbexa
reference
abx270798
tested applications
FCM

Description

Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) Antibody (PE) is a Mouse Monoclonal Antibody conjugated to PE against Ubiquitin Carboxyl Terminal Hydrolase L1 (UCHL1) for use in flow cytometry.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetUbiquitin Carboxyl Terminal Hydrolase L1 (UCHL1)
HostMouse
ReactivityHuman
Recommended DilutionFCM: 1-5 µl/106 cells. Optimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
ConjugationPE
IsotypeIgG
PurificationPurified by Protein A and Protein G affinity chromatography.
Size 1100 tests
Size 2200 tests
Size 3500 tests
FormLiquid
Tested ApplicationsFCM
Buffer0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
AvailabilityShipped within 5-15 working days.
StorageAliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light.
Dry IceNo
AliasHEL-117,HEL-S-53,NDGOA,PARK5 PGP 9.5,PGP9.5,PGP95,SPG79,SPG79A,UCHL-1 Uch-L1,Neuron cytoplasmic protein 9.5,Ubiquitin thioesterase L1
BackgroundAntibody anti-UCHL1
StatusRUO

Descripción

UCHL1 is a deubiquitinating enzyme that cleaves ubiquitin from protein substrates, playing a pivotal role in the ubiquitin-proteasome system (UPS). UCHL1 is highly expressed in neurons and is crucial for maintaining protein homeostasis, axonal transport, and synaptic function. It regulates the degradation of misfolded proteins, ensuring neuronal survival and preventing neurotoxicity. Mutations in UCHL1 are linked to neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease due to impaired protein turnover and accumulation of toxic aggregates. It also has oncogenic and tumor-suppressive roles depending on the cellular context, regulating cell cycle progression and apoptosis. Knockout studies in mice show progressive neurodegeneration, motor dysfunction, and impaired synaptic activity, highlighting UCHL1’s critical role in neuronal maintenance, proteostasis, and neuroprotection.

Related Products

EH1908

Human UCHL1(Ubiquitin carboxyl-terminal hydrolase isozyme L1) ELISA Kit

Ver Producto
EM1438

Mouse UCHL1(Ubiquitin Carboxyl Terminal Hydrolase L1) ELISA Kit

Ver Producto
ER1417

Rat UCHL1(Ubiquitin Carboxyl Terminal Hydrolase L1) ELISA Kit

Ver Producto